Loading...

PTIX PROTAGENIC THERAPEUTICS INC Management Changes 8-K Filing

PRTG

PTX

PROTAGENIC THERAPEUTICS INC

(PTIX)

2025 8-K

Delisting Notification

Director Resignation

Legal Action Filed

Acquisition Update

Company Acquisition

Accounting Changes

Restructuring Plan

Rights Offerings

Warrant Exercises

Warrant Exchange

Asset Acquisitions

Stock Split Approval

Stock Option Repricing

Annual Meeting Results

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Filing with Quantitative Data

Quantitative Data

Annual Meeting Results

Quantitative Data

Reverse Stock Split

External Links:

Protagenic Therapeutics, Inc. filed an 8-K on August 7, 2025, indicating a change in its independent auditors from MaloneBailey to Green Growth CPAs, with no disagreements reported. Additionally, the company faces a compliance issue with Nasdaq due to a delayed Form 10-Q filing and is working on solutions to regain compliance.

AI Assistant

PROTAGENIC THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.